JPMorgan Chase & Co. is a leading global financial services firm that provides a wide range of financial solutions to consumers, businesses, and governments. The company offers investment banking, asset management, private banking, and wealth management services while also delivering a full suite of commercial banking products. With a strong emphasis on innovation and technology, JPMorgan Chase plays a pivotal role in the financial market, helping clients navigate complex financial landscapes through expert advice and tailored services. The firm is committed to maintaining its reputation for integrity and professionalism while actively contributing to economic development and community investment. Read More
Veteran real estate finance attorney Michael Fralin, known for steering complex billion-dollar deals and helping build real estate private equity firm SomeraRoad from the ground up, is turning his attention to something more personal—and far more universal: how professionals can work with more intention, not more hours.
Shares of blockchain infrastructure company Coinbase (NASDAQ:COIN) jumped 3.6% in the morning session after it announced a strategic partnership with JPMorgan Chase to make cryptocurrency more accessible to the bank's customers.
The Independent Restaurant Coalition (IRC) and Chase today announced a multi-year partnership to offer meaningful support to independent restaurants and bars as they continue to be vital employers and leaders in communities nationwide.
Today, JPMorganChase (NYSE: JPM) and Coinbase (NASDAQ: COIN) announced a strategic partnership that sets a new standard for customer choice and security in the innovation economy. This collaboration introduces features designed to enhance access and optionality for our mutual customers.
A number of stocks fell in the afternoon session after reports pointed to a broad-based weakening of consumer health, highlighted by rising loan delinquencies and falling spending intentions.
Shares of semiconductor design software provider Cadence Design Systems (NASDAQ:CDNS) jumped 9.1% in the afternoon session after the company reported strong second-quarter results that surpassed analyst expectations and raised its full-year financial outlook. The electronic design automation (EDA) company, which provides software and hardware for designing semiconductors, posted second-quarter adjusted earnings of $1.65 per share on revenue of $1.28 billion. This revenue figure represented a 20% increase year-over-year, and both metrics beat analyst forecasts. The strong performance was attributed to high demand from the artificial intelligence, high-performance computing, and automotive sectors. This result came despite Cadence disclosing a one-time charge of $140.6 million to settle legal proceedings with the U.S. government over its business operations in China. Investors appeared to focus on the strong results, as the company also increased its 2025 revenue forecast to a range of $5.21 billion to $5.27 billion and its adjusted EPS guidance to between $6.85 and $6.95. Following the news, analysts at firms including J.P. Morgan and Wells Fargo raised their price targets.
Barclays PLC, one of the most influential financial institutions in the world today, traces its origins back over three centuries to the coffee houses and counting houses of London. From its modest beginnings as a Quaker-led partnership to becoming a pillar of international banking, Barclays has evolved through mergers, innovations,
Shares of health coverage company Centene (NYSE:CNC)
fell 3.3% in the morning session after JPMorgan cut its price target on the managed care company to $30 from $48. This move by JPMorgan followed Centene's recent second-quarter earnings report, where the company posted a loss of $0.16 per share, missing analyst estimates. The poor results were largely attributed to a significant reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, an issue that first came to light when Centene withdrew its full-year guidance on July 1st. The company's performance prompted a series of downgrades from Wall Street, with firms like UBS, Wells Fargo, and Morgan Stanley also cutting their price targets, signaling widespread concern over the company's ability to restore its earnings trajectory.
Jaypirca had an overall response rate better than AbbVie’s Imbruvica in the study, meaning a higher percentage of patients treated with Jaypirca experienced their cancer shrink or disappear after treatment.
The deal could be announced as early as later this week, according to a report by The Wall Street Journal, which estimates that CyberArk could be valued at over $20 billion.
JPMorgan Chase is in late-stage negotiations to take over Apple's credit card partnership, per a WSJ report. The discussions, which began in early 2024, have reportedly accelerated.
Qualcomm heads into earnings with bullish analyst upgrades, a steady uptrend, and breakout potential. This report could finally unlock its next leg higher.
